LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

LLY

917.82

+3.36%↑

JNJ

243.26

+0.5%↑

ABBV

216.83

+1.6%↑

NVS

151.64

+0.81%↑

MRK

119.41

+1.21%↑

Search

ResMed Inc

Ouvert

SecteurSoins de santé

224.46 2.06

Résumé

Variation du prix de l'action

24h

Actuel

Min

218.73

Max

224.6

Chiffres clés

By Trading Economics

Revenu

44M

393M

Ventes

87M

1.4B

P/E

Moyenne du Secteur

22.571

57.05

Rendement du dividende

1

Marge bénéficiaire

27.593

Employés

10,600

EBITDA

63M

566M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+34.35% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.00%

2.52%

Prochains Résultats

22 avr. 2026

Date du Prochain Dividende

11 juin 2026

Date du Prochain Détachement de Dividende

7 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-4B

33B

Ouverture précédente

222.4

Clôture précédente

224.46

Sentiment de l'Actualité

By Acuity

27%

73%

83 / 349 Classement par Healthcare

ResMed Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 mars 2026, 23:15 UTC

Principaux Événements d'Actualité

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 mars 2026, 22:36 UTC

Principaux Événements d'Actualité

Australian Government Rules Out Boots on the Ground in the Middle East

30 mars 2026, 22:13 UTC

Acquisitions, Fusions, Rachats

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 mars 2026, 21:00 UTC

Résultats

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 mars 2026, 20:15 UTC

Principaux Événements d'Actualité

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 mars 2026, 23:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mars 2026, 23:40 UTC

Market Talk

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 mars 2026, 23:36 UTC

Market Talk

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 mars 2026, 23:12 UTC

Market Talk

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 mars 2026, 22:49 UTC

Market Talk

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 mars 2026, 22:44 UTC

Market Talk

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 mars 2026, 22:43 UTC

Market Talk

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 mars 2026, 22:42 UTC

Market Talk

South32 Should Go for Growth, Says New Bull -- Market Talk

30 mars 2026, 22:18 UTC

Market Talk

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 mars 2026, 22:05 UTC

Market Talk

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 mars 2026, 21:58 UTC

Acquisitions, Fusions, Rachats

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 mars 2026, 21:39 UTC

Acquisitions, Fusions, Rachats

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 mars 2026, 21:38 UTC

Acquisitions, Fusions, Rachats

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 mars 2026, 21:36 UTC

Acquisitions, Fusions, Rachats

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 mars 2026, 21:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mars 2026, 21:25 UTC

Market Talk

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 mars 2026, 21:03 UTC

Acquisitions, Fusions, Rachats

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 mars 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 mars 2026, 20:09 UTC

Résultats

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 mars 2026, 20:00 UTC

Principaux Événements d'Actualité

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Comparaison

Variation de prix

ResMed Inc prévision

Objectif de Prix

By TipRanks

34.35% hausse

Prévisions sur 12 Mois

Moyen 296.2 USD  34.35%

Haut 345 USD

Bas 265 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

12 ratings

7

Achat

5

Maintien

0

Vente

Sentiment

By Acuity

83 / 349Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat